These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6128655)

  • 1. Binding characteristics of mu and kappa agonists in rat brain subcellular fractions.
    Monferini E; Adler MW; Simon EJ
    Life Sci; 1982 Sep 20-27; 31(12-13):1295-8. PubMed ID: 6128655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of opioid receptor binding in brain slices.
    Barchfeld-Rothschild CC; Medzihradsky F
    J Neurosci Res; 1987; 18(2):358-65. PubMed ID: 2891857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3H-dihydromorphine binding sites in subcellular fractions of rat striatum.
    Antkiewicz-Michaluk L; Vetulani J; Havemann U; Kuschinsky K
    Pol J Pharmacol Pharm; 1982; 34(1-3):73-8. PubMed ID: 6300816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of two different buffers on the high affinity 3H-ethylketocyclazocine and 3H-SKF10047 binding to guinea pig brain membranes.
    Grynne BH; Maurset AR; Holmen AT; Enger M
    Acta Pharmacol Toxicol (Copenh); 1984 Mar; 54(3):195-200. PubMed ID: 6144235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution in the receptor binding of putative mu and kappa opiates.
    Medzihradsky F; Dahlstrom PJ; Woods JH; Fischel SV; Mitsos SE
    Life Sci; 1984 May; 34(22):2129-38. PubMed ID: 6145076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinities of some common opioid analgesics towards four binding sites in mouse brain.
    Neil A
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):24-9. PubMed ID: 6151117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity [3H]ethylketazocine binding: evidence for specific kappa receptors.
    Wood PL; Charleson S
    Neuropharmacology; 1982 Mar; 21(3):215-9. PubMed ID: 6122185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
    Nishimura S; Pasternak GW
    Brain Res; 1982 Sep; 248(1):192-5. PubMed ID: 6289993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of kappa- and sigma-opiates in rat brain.
    Wolozin BL; Nishimura S; Pasternak GW
    J Neurosci; 1982 Jun; 2(6):708-13. PubMed ID: 6283040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding to rat brain homogenates of Mr2034, a universal opiate.
    Johnson N; Pasternak GW
    Life Sci; 1983 Sep; 33(10):985-91. PubMed ID: 6310291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of guanyl nucleotides and ions on kappa opioid binding.
    Mack KJ; Lee MF; Weyhenmeyer JA
    Brain Res Bull; 1985 Apr; 14(4):301-6. PubMed ID: 2988712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
    Chavkin C; James IF; Goldstein A
    Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of benzomorphan-selective (kappa) sites: a computerized analysis.
    Spain JW; Bennett DB; Roth BL; Coscia CJ
    Life Sci; 1983; 33 Suppl 1():235-8. PubMed ID: 6141487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct high-affinity binding sites for benzomorphan drugs and enkephalin in a neuroblastoma--brain hybrid cell line.
    McLawhon RW; West RE; Miller RJ; Dawson G
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4309-13. PubMed ID: 6117074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of rat brain opioid receptors by cannabinoids.
    Vaysse PJ; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterograde transport of opioid receptors in rat vagus nerves and dorsal roots of spinal nerves: pharmacology and sensitivity to sodium and guanine nucleotides.
    Zarbin MA; Wamsley JK; Kuhar MJ
    Exp Brain Res; 1990; 81(2):267-78. PubMed ID: 1697808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the affinity ligands 14-beta-chloroacetylnaltrexone and 14-beta-bromoacetamidomorphine on [3H]-dihydromorphine binding sites in rat brain.
    Reichman M; Dirksen R; Abood LG; Gala D
    Biochem Pharmacol; 1986 Nov; 35(22):3995-8. PubMed ID: 3022745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.